BioMarin Pharmaceutical
BMRN
$83.73
Share price
6.33%
Change (1 day)
-29.31%
Change (1 year)
Categories
Revenue for BioMarin Pharmaceutical (BMRN)
Revenue in 2024 (TTM): C$3.93 Billion
According to BioMarin Pharmaceutical's latest financial reports the company's current revenue (TTM 
) is C$4.02 Billion. an increase over the revenue in the year 2023 that were of C$3.20 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for BioMarin Pharmaceutical from 1999 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | C$4.09 B | 27.63% |
| 2023 | C$3.20 B | 12.82% |
| 2022 | C$2.84 B | 20.88% |
| 2021 | C$2.35 B | -0.81% |
| 2020 | C$2.37 B | 6.59% |
| 2019 | C$2.22 B | 9.56% |
| 2018 | C$2.03 B | 22.99% |
| 2017 | C$1.65 B | 10.04% |
| 2016 | C$1.50 B | 21.58% |
| 2015 | C$1.23 B | 41.69% |
| 2014 | C$0.87 B | 49.22% |
| 2013 | C$0.58 B | 17.26% |
| 2012 | C$0.49 B | 10.91% |
| 2011 | C$0.44 B | 19.36% |
| 2010 | C$0.37 B | 10.1% |
| 2009 | C$0.34 B | -5.24% |
| 2008 | C$0.36 B | 197.22% |
| 2007 | C$0.12 B | 23.71% |
| 2006 | C$98.04 M | 228.07% |
| 2005 | C$29.88 M | |
| 2002 | C$21.98 M | 33.5% |
| 2001 | C$16.46 M | -10.83% |
| 2000 | C$18.46 M | 83.44% |
| 1999 | C$10.06 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | C$0.78 B | -80.37% | 🇺🇸 USA |
 | C$81.43 M | -97.97% | 🇺🇸 USA |
 | C$0.46 B | -88.36% | 🇺🇸 USA |
 | C$67.57 B | 1,580.51% | 🇫🇷 France |
 | C$0.74 B | -81.49% | 🇺🇸 USA |
 | C$0.69 B | -82.77% | 🇺🇸 USA |